Kenneth M. Cohen, President and CEO at Somaxon Pharmaceuticals, Inc. (SOMX), sold 5,000 shares at $12.62 ($64K) on 2006-09-26, disclosed to the SEC on 2006-09-27.
Scheduled sale ($64k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.84 | 3,689 | $47K | 74.1% |
| 2 | $12.62 | 1,311 | $17K | 25.9% |
| Total | $12.78 avg | 5,000 | $64K | 100% |
| Filing → |
| MBVX | BUY | 2014-12-18 | $5K | — | Filing → |
| MBVX | BUY | 2014-12-17 | $10K | — | Filing → |
| SOMX | SELL | 2007-04-27 | $360K | — | Filing → |